About Kern Pharma

Kern Pharma is a pharmaceutical laboratory that is part of the family-based company Grupo Indukern. Its activity currently centres around six lines of business:

Generic Medicinal Products

Kern Pharma is a leader in the development, manufacturing and marketing of generic medicinal products.

Consumer

It is the division focused on marketing products for pharmaceutical recommendation.

Biologics

Biologics is Kern Pharma's division focused on biosimilar medicines.

Women’s health

Under the brand GyneaKern Pharma markets a wide range of products for women’s health.

Finisher®

Kern Pharma markets its line of health and sports nutrition under this brand.

Production for third parties

Kern Pharma has the confidence of large companies in the sector that entrust the manufacture of their products.

Actafarma

With the acquisition of Actafarma, Kern Pharma has strengthened its self-care product line.

Internationally, the laboratory has two subsidiaries, one in Portugal, Pharma Kern, and another one in the United States. In addition, the company carries out important export activities, manufacturing products for international laboratories and boosting internationalisation of its products through agreements with local distributors. Currently, Kern Pharma It is present in almost all the countries of the European Union.

The company adheres to its growth strategy by investing in R+D+I with the aim of generating and maintaining an optimum product portfolio that allows it to cover the current and future needs of the market.

Its team, consisting of more than 890 professionals, is responsible for offering the best solutions to patients, doctors and pharmacists day after day.

Kern Pharma in figures

Comprehensive quality policy

Kern Pharma’s management system for comprehensive quality, within which it carries out its activities, is another demonstration of its commitment to health, people’s quality of life and sustainability.

The aim is to work efficiently regarding the quality of the product, quality of the service, prevention of occupational risks and environmental protection. To do this, all parties need to be involved from the management of the company to the suppliers and distributors, passing through to each and every one of our collaborators.

 

Organisation

Kern Pharma has a team with extensive experience in the sector led by:

Raúl Díaz-Varela

Executive Vice President of Grupo Indukern

CEO of Kern Pharma

Manuel Garrido

General Director of Kern Pharma

Kern Pharma is organised into five large areas which allows it to successfully face future challenges: Commercial and MarketingStrategy and Development, Export and contract Manufacturing for third parties, Operations and Quality.